Lucid Diagnostics Inc.
LUCD
$1.26
-$0.03-2.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.46% | 13.55% | 21.05% | 18.01% | 21.81% |
| Total Depreciation and Amortization | -62.86% | -53.30% | -36.66% | -19.12% | -5.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 190.26% | -60.15% | -69.89% | -53.94% | -62.08% |
| Change in Net Operating Assets | -600.57% | -178.08% | -146.69% | -132.72% | -103.92% |
| Cash from Operations | -14.84% | -34.50% | -63.30% | -73.77% | -23.46% |
| Capital Expenditure | -46.06% | -33.94% | 14.86% | 59.35% | 68.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -191.29% | -192.31% | -125.70% | 85.48% | 93.94% |
| Total Debt Issued | -- | 116.15% | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,300.63% | -45.99% | -46.05% | -74.55% | -78.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -49.78% | 59.99% | 155.40% | 155.40% | 70.02% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.79% | 63.77% | 44.10% | 35.71% | -10.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.18% | 196.76% | -231.52% | -6,918.35% | -75.69% |